Staying ahead in the pharma and medtech sectors requires a deep understanding of regulatory and advisory timelines, such as those set by the PBAC (Pharmaceutical Benefits Advisory Committee) and MSAC (Medical Services Advisory Committee). These calendars outline critical submission deadlines, evaluation periods, and decision points that shape reimbursement and market access in Australia—key factors in determining when your product can reach patients and generate revenue. Aligning product development milestones with these dates ensures timely submissions, while missing a cycle could delay market entry by months, impacting competitive positioning. Equally important, the schedules of competitor applications, often visible through public PBAC and MSAC meeting agendas, reveal when rival products might secure listings, allowing you to anticipate market shifts and refine your strategy. We’ve embedded the PBAC and MSAC calendars here as a practical tool to help you stay informed about key dates.
The PBAC cycle
The MSAC cycle
